The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer.
about
Present and changing trends in surgical modalities and neoadjuvant chemotherapy administration for female breast cancer in Beijing, China: A 10-year (2006-2015) retrospective hospitalization summary report-based study.Oral Administration of Improves the Effect of Taxane on Preventing the Progression of Breast Cancer and Reduces Its Side Effects
P2860
The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The survival benefit of neoadj ...... triple negative breast cancer.
@en
The survival benefit of neoadj ...... triple negative breast cancer.
@nl
type
label
The survival benefit of neoadj ...... triple negative breast cancer.
@en
The survival benefit of neoadj ...... triple negative breast cancer.
@nl
prefLabel
The survival benefit of neoadj ...... triple negative breast cancer.
@en
The survival benefit of neoadj ...... triple negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
The survival benefit of neoadj ...... triple negative breast cancer.
@en
P2093
Charulata Jindal
Jimmy T Efird
Paul R Walker
Shreya Prasad
Tithi Biswas
P2860
P304
112712-112719
P356
10.18632/ONCOTARGET.22521
P407
P577
2017-11-20T00:00:00Z